Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement
BBH
US Health Care
Passive

VanEck Biotech ETF

This ETF provides exposure to US Biotechnology Equities

BBH performance and flow charts

Last update 8/5/2026 at 3:03 PM
Live
Closed
Last price
$211.44
+$3.41 (+1.64%) Today

Performance

-4.0-3.0-2.0-1.00.01.0%Jul 6Jul 13Jul 20Jul 27Aug 3

Flows

0
1 day price range
$211.44
$211.44
52 week price range
$157.60
$212.29
1W perf
-0.89%
YTD perf
+9.98%
YTD flows
-$7M
AuM
$405M
E/R
0.35%
TTM yield
0.46%
Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

Historic performance and flows

Data as of August 4, 2026
1M3MYTD1Y3Y5Y
Perf.-1.02%+12.06%+9.98%+26.54%+32.94%-1.92%
Flows--$4M-$7M-$28M-$180M-$139M
Data as of August 4, 2026
Advertisement

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Characteristics

The VanEck Biotech ETF is built to track the MVIS US Listed Biotech 25 Net Total Return Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.

Management strategyPassive
StrategyLong Only
ProviderVanEck
N° of holdings24
Replication methodDirect (Physical)
Asset classEquity
Dividend policyDistributing
Trailing 12m distribution yield
Join for free
Inception dateDecember 20, 2011
ESGNo
TrackinsightTrackinsight

More data and info about BBH on Trackinsight

Exposure

Data as of June 30, 2026

Diversification

85.08%

Total weight of top 15 holdings out of 24

Top 15 Holdings

Amgen, Inc.
15.15%
Gilead Sciences, Inc.
12.75%
Vertex Pharmaceuticals, Inc.
9.15%
Regeneron Pharmaceuticals, Inc.
6.26%
Revolution Medicines, Inc.
5.41%
Natera, Inc.
4.92%
argenx SE
4.88%
IQVIA Holdings, Inc.
4.3%
Alnylam Pharmaceuticals, Inc.
3.73%
Biogen, Inc.
3.63%
Moderna, Inc.
3.34%
Illumina, Inc.
3.26%
BeOne Medicines Ltd.
2.85%
United Therapeutics Corp.
2.84%
Insmed, Inc.
2.62%

Sectors

Healthcare
100%

Countries

USA
87.33%
Other
12.67%
Advertisement

Trading data

Last sale
8/5/2026 at 3:03 PM
$211.44
Previous close
$208.03
Consolidated volume
08/04/2026
Join for free
Average volume
30 days
Join for free
Average discount or premium
30 days
Join for free
Average Bid/Ask spread
30 days
Join for free

Volatility and drawdown

3M1Y3Y5Y
Volatility+21.02%+19.52%+19.25%+21.50%
Max drawdown
-5.29%-10.54%-22.78%-39.88%
Max drawdown duration
28d150d440d1821d
Time to recover
N/A40d180dN/A

Replication quality

Data as of July 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free
Tracking error
Join for free
Tracking difference
Join for free
1 year cumulative return difference
Best
Join for free
Worst
Join for free
daily return difference
Average
Join for free
Worst
Join for free
Advertisement
Frequently asked questions about BBH

What type of ETF is BBH?

BBH is a Passive ETF that provides exposure to Equity assets. It is managed by VanEck.

What index does BBH track?

BBH tracks the MVIS US Listed Biotech 25 Net Total Return Index - USD, aiming to replicate its performance through full replication.

What does BBH invest in?

This ETF provides exposure to US Biotechnology Equities. It is part of the segment: US Health Care.

What is the expense ratio of BBH?

The total expense ratio (TER) of BBH is 0.35%, representing the annual fee charged by the fund manager.

When was BBH launched?

BBH was launched on December 20, 2011, marking its entry into the ETF market.

Who is the issuer of BBH?

BBH is issued by VanEck.

What is the AUM of BBH?

As of August 4, 2026, BBH manages $404.99 M, reflecting the total assets held in the fund.

How has BBH performed recently?

As of August 4, 2026, BBH delivered a return of -1.02% over the past month (1M performance), 12.06% over the past three months (3M), and 9.98% year-to-date (YTD).

Does BBH pay dividends?

As of August 4, 2026, BBH has a trailing 12-month distribution yield of 0.46%.

How many holdings are in BBH

As of June 30, 2026, BBH holds 24 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.

How diversified is BBH?

As of June 30, 2026, BBH holds 24 securities, with 85.08% of its assets concentrated in its top 15 holdings.

What are the top holdings of BBH?

As of June 30, 2026, BBH holds a portfolio of 24 underlyings, with its largest positions including Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc.. These top holdings play a significant role in shaping the fund’s performance and exposure.

What countries or regions does BBH invest in?

As of June 30, 2026, BBH has its largest geographic exposures in USA.

What sectors or themes does BBH focus on?

As of June 30, 2026, BBH is primarily exposed to Healthcare.

The ETF Institute® is now affiliated with ETF Central

The CETF certification is the only FINRA listed professional designation focused on ETFs.

ETF Institute
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides
Advertisement

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 20, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 20, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 13, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 14, 2026
First Look ETF: Cash Deployment, Bond, and Hedged ETFs

First Look ETF

First Look ETF: Cash Deployment, Bond, and Hedged ETFs

In this season 6 episode of First Look ETF, Stephanie Stanton ‪examines the latest ETF marketplace trends with NYSE and guests.

ETF Guide
By ETF Guide · July 10, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs July 6, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · July 7, 2026

Browse all educational columns

Advertisement
Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey and get exclusive early access to the final report.

Global ETF Survey 2026